Statins and diabetes mellitus: price of collaboration
It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incid...
Guardado en:
Autores principales: | Andrey Alexeevich Aleksandrov, Maria Nikolaevna Yadrikhinskaya, Svetlana Semenovna Kukharenko, Olga Alexandrovna Shatskaya |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2010) -
Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2011) -
Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012) -
ACE inhibitors as a risk factor for hypoglycemia
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2011) -
Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
por: Victoriya N. Serebryakova, et al.
Publicado: (2021)